Featured news
-
25-Nov-2009
BioCamp prompts young scholars to look at biotechToday’s best young minds will soon be changing the world. Novartis has created a unique global initiative encouraging top students to apply their intellects in the biotechnology industry – and to think like entrepreneurs.
-
25-Nov-2009
Good governance in economic crisisA board of directors can restore confidence in the wake of a financial meltdown. On a panel at Yale University, Novartis General Counsel Thomas Werlen helps outline the qualities of a successful board.
-
12-Nov-2009
New treatment option for frequent heartburnMore than 50 million American adults suffer from frequent heartburn. Painful symptoms can disrupt their lives. Now Novartis Consumer Health offers Prevacid®24HR, a new way to treat frequent heartburn over-the-counter.
-
19-Oct-2009
Novartis committed to new therapies for multiple sclerosis (MS) communityRecent advances in science are enabling new treatments with greater efficacy and more convenient delivery. Novartis is investing significant resources to deliver these treatments to patients with MS.
-
01-Oct-2009
Easing the pain of cats and dogsAn innovative new Novartis product brings fast, effective relief of pain and inflammation for pets. Onsior, launched in Europe, is the first medication of its class for cats and dogs. The range of dosing options offer convenience for veterinarians and pet owners.
Read the article (for non-US residents only)
-
08-Sep-2009
Novartis marks 20-year commitment in the fight against leprosyThe once-dreaded disease leprosy is on the brink of elimination, but the fight goes on. Novartis commemorates 20 years of helping deliver free care, drugs and rehabilitation in India.
-
22-Jul-2009
Novartis addresses climate changeWorld leaders are focused on climate change and Novartis is, too. Our cutting-edge energy efficiency strategy is a driving long-term success for the environment and for our business.
-
20-May-2009
Life-saving research rewardedScientists who developed Novartis Coartem and Glivec receive 2009 "European Inventor of the Year" awards.
-
24-Apr-2009
Novartis in the fight against malariaApril 25 is World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria.
-
31-Mar-2009
A Revolutionary CollaborationWith declining efficacy and resistance to existing sheep worm treatments on the rise, Novartis Animal Health worked together with sheep farmers and veterinarians to develop an unparalleled new treatment.
-
19-Mar-2009
Novartis in the fight against tuberculosisAs World TB Day on March 24 raises global awareness, Novartis remains a committed partner in the struggle.
-
27-Feb-2009
A rare opportunityThe challenges of developing products in rare diseases are many - but no obstacle for Novartis Development teams.
-
04-Feb-2009
Meeting healthcare needs in emerging marketsNovartis is working to expand its offering in emerging markets including Brazil, Russia, India and China.
The information in the feature stories on these pages was factually accurate on the date of publication. These feature stories remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
